Skip to main content
. 2017 Nov 8;23:5321–5329. doi: 10.12659/MSM.904928

Figure 1.

Figure 1

BRAFV600E and RET/PTC activated NF-κB and pyrrolidine dithiocarbamate (PDTC) suppressed NF-κB. * TPC-1+PDTC(−) vs. BCPAP+PDTC(−) or PCCL3+PDTC(−) vs. PTC3-5+PDTC(−), P<0.05; # TPC-1+PDTC(+) vs. BCPAP +PDTC(+) or PCCL3+PDTC(+) vs. PTC3-5+PDTC(+), P<0.05; @ TPC-1+PDTC(−) vs. TPC-1+PDTC(+) or PCCL3+PDTC(−) vs. PCCL3+PDTC(+), P<0.05; & BCPAP +PDTC(−) vs. BCPAP +PDTC(+) or PTC3-5+PDTC(−) vs. PTC3-5+PDTC(+), P<0.05.